Discontinuation report ACETAMINOPHEN, CAFFEINE & CODEINE
Report ID | 25692 |
Drug Identification Number | 02028174 |
Brand name | ACETAMINOPHEN, CAFFEINE & CODEINE |
Common or Proper name | ACETA COD |
Company Name | PHARMASCIENCE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE |
Strength(s) | 300MG 8MG 15MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 50 |
ATC code | N02AJ |
ATC description | OPIOIDS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2017-10-12 |
Actual discontinuation date | 2017-10-12 |
Remaining supply date | 2017-10-12 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | NO REMAINING SUPPLY - PRODUCT DISCONTINUED |
Company comments | PRODUCT DISCONTINUED |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2017-10-13 | English | Compare |
v5 | 2017-10-12 | French | Compare |
v4 | 2017-10-12 | English | Compare |
v3 | 2017-10-12 | French | Compare |
v2 | 2017-10-12 | French | Compare |
v1 | 2017-10-12 | English | Compare |
Showing 1 to 6 of 6